Prospective evaluation of quality of life after interstitial brachytherapy for localized prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 1, 2006, Pages 31-37

  Caffo, Orazio ^a   Fellin, Gianni ^a   Bolner, Andrea ^a   Coccarelli, Franco ^a   Divan, Claudio ^a   Frisinghelli, Michela ^a   Mussari, Salvatore ^a   Ziglio, Franco ^a   Malossini, Gianni ^a   Tomio, Luigi ^a   Galligioni, Enzo ^a  

^a SANTA CHIARA HOSPITAL   (Italy)

Author keywords

Brachytherapy; Prostate cancer; Quality of life

Indexed keywords

HOSPITALS; KNOWLEDGE ACQUISITION; PSYCHOPHYSIOLOGY; TOXICITY; TUMORS;

BRACHYTHERAPY; PROSTATE CANCER; QUALITY OF LIFE; URINARY FUNCTION;

PATIENT MONITORING;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER LOCALIZATION; CLINICAL TRIAL; DIGESTIVE SYSTEM FUNCTION DISORDER; EVALUATION; GASTROINTESTINAL TRACT FUNCTION; HUMAN; INDEPENDENCE; MAJOR CLINICAL STUDY; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SEXUAL DYSFUNCTION; URINARY DYSFUNCTION; WELLBEING;

AGED; BRACHYTHERAPY; COITUS; HEALTH SURVEYS; HUMANS; INTERPERSONAL RELATIONS; MALE; MENTAL HEALTH; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RECTAL DISEASES; URINATION DISORDERS;

EID: 33746848965     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.04.009     Document Type: Article

References (40)

1. Kupelian P.A., Potters L., Khuntia D., et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or = 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 25-33
2. Brachman D.G., Thomas T., Hilbe J., et al. Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients. Results from a single practice. Int J Radiat Oncol Biol Phys 48 (2000) 111-117
3. Beyer D.C., and Brachman D.G. Failure free survival following brachytherapy alone for prostate cancer. Comparison with external beam radiotherapy. Radiother Oncol 57 (2000) 263-267
4. Stokes S.H. Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation. Int J Radiat Oncol Biol Phys 47 (2000) 129-136
5. Greene F.L., Page D.L., Fleming I.D., Fritz A.G., Balch C.M., Haller D.G., and Morrow M. American Joint Committee on Cancer (AJCC) Cancer staging manual. 6th ed. (2002), Springer, New York 309-316
6. Nag S., Ciezki J.P., Cormack R., et al. Intraoperative planning and evaluation of permanent prostate brachytherapy. Report of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 51 (2001) 1422-1430
7. Caffo O., Fellin G., Graffer U., et al. Assessment of quality of life after radical radiotherapy for prostate cancer. Br J Urol 78 (1996) 557-563
8. D'Amico A.V., Whittington R., Kaplan I., et al. Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of >4-20 ng/ml. Int J Radiat Oncol Biol Phys 37 (1997) 1053-1058
9. Hummel S., Paisley S., Morgan A., et al. Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer. A systematic review. Health Technol Assess 7 (2003) 33
10. Aaronson N.K., Meyerowitz B.E., Bard M., et al. Quality of life research in oncology. Past achievements and future priorities. Cancer 67 (1991) 839-843
11. Eton D.T., and Lepore S.J. Prostate cancer and health-related quality of life. A review of the literature. Psychooncology 11 (2002) 307-326
12. Brandeis J.M., Litwin M.S., Burnison C.M., et al. Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol 163 (2000) 851-857
13. Joly F., Brune D., Couette J.E., et al. Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer. Ann Oncol 9 (1998) 751-757
14. Krupski T., Petroni G.R., Bissonette E.A., et al. Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer. Urology 55 (2000) 736-742
15. Lee W.R., McQuellon R.P., Harris-Henderson K., et al. A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 46 (2000) 77-81
16. Lee W.R., Hall M.C., McQuellon R.P., et al. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. Int J Radiat Oncol Biol Phys 51 (2001) 614-623
17. Feigenberg S.J., Lee W.R., Desilvio M.L., et al. Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05. Int J Radiat Oncol Biol Phys 62 (2005) 956-964
18. Cesaretti J.A., Stone N.N., and Stock R.G. Urinary symptom flare following I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 56 (2003) 1085-1092
19. Blasko J.C., Ragde H., and Grimm P.D. Transperineal ultrasound-guided implantation of the prostate. Morbidity and complications. Scand J Urol Nephrol Suppl 137 (1991) 113-118
20. Kleinberg L., Wallner K., Roy J., et al. Treatment-related symptoms during the first year following transperineal 125I prostate implantation. Int J Radiat Oncol Biol Phys 28 (1994) 985-990
21. Wallner K., Roy J., and Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol 14 (1996) 449-453
22. Desai J., Stock R.G., Stone N.N., et al. Acute urinary morbidity following I-125 interstitial implantation of the prostate gland. Radiat Oncol Investig 6 (1998) 135-141
23. Gelblum D.Y., Potters L., Ashley R., et al. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys 45 (1999) 59-67
24. Merrick G.S., Butler W.M., Lief J.H., et al. Temporal resolution of urinary morbidity following prostate brachytherapy. Int J Radiat Oncol Biol Phys 47 (2000) 121-128
25. Arterbery V.E., Frazier A., Dalmia P., et al. Quality of life after permanent prostate implant. Semin Surg Oncol 13 (1997) 461-464
26. Wagner T.T., Nag S., Young D., et al. Early voiding dysfunction associated with prostate brachytherapy. Urol Oncol 6 (2001) 20-23
27. Merrick G.S., Butler W.M., Wallner K.E., et al. Dysuria after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 55 (2003) 979-985
28. Stone N., and Stock R.G. Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy. Brachytherapy 2 (2003) 32-39
29. Merrick G.S., Butler W.M., Dorsey A.T., et al. Rectal function following prostate brachytherapy. Int J Radiat Oncol Biol Phys 48 (2000) 667-674
30. Merrick G.S., Butler W.M., Wallner K.E., et al. Late rectal function after prostate brachytherapy. Int J Radiat Oncol Biol Phys 57 (2003) 42-48
31. Talcott J.A., Clark J.A., Stark P.C., et al. Long-term treatment related complications of brachytherapy for early prostate cancer. A survey of patients previously treated. J Urol 166 (2001) 494-499
32. Merrick G.S., Butler W.M., Wallner K.E., et al. Rectal function following brachytherapy with or without supplemental external beam radiation. Results of two prospective randomized trials. Brachytherapy 2 (2003) 147-157
33. Schover L.R., Fouladi R.T., Warneke C.L., et al. Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer 95 (2002) 1773-1785
34. Penson D.F., Litwin M.S., and Aaronson N.K. Health related quality of life in men with prostate cancer. J Urol 169 (2003) 1653-1661
35. Potters L., Torre T., Fearn P.A., et al. Potency after permanent prostate brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 50 (2001) 1235-1242
36. Merrick G.S., Butler W.M., Galbreath R.W., et al. Erectile function after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 52 (2002) 893-902
37. Stock R.G., Kao J., and Stone N.N. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 165 (2001) 436-439
38. Stock R.G., Stone N.N., and Iannuzzi C. Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 35 (1996) 267-272
39. Valicenti R.K., Bissonette E.A., Chen C., et al. Longitudinal comparison of sexual function after 3-dimensional conformal radiation therapy or prostate brachytherapy. J Urol 168 (2002) 2499-2504
40. Zelefsky M.J., Wallner K.E., Ling C.C., et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 17 (1999) 517-522